Electronic health record-based cardiac risk assessment and identification of unmet preventive needs

Medical Care

Volumn 47, Issue 4, 2009, Pages 418-424

  Persell, Stephen D ^a,b,c   Dunne, Alexis P ^a   Lloyd Jones, Donald M ^a   Baker, David W ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Computerized; Coronary disease; Healthcare; Medical records systems; Outcome and process assessment; Prevention and control

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT;

ACCURACY; ADULT; AGED; ARTICLE; AUTOMATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DATA ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH CARE NEED; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; URBAN AREA; DECISION SUPPORT SYSTEM; HEALTH SERVICE; MEDICAL AUDIT; MEDICAL RECORD; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PREVENTIVE MEDICINE;

ADULT; AGED; CARDIOVASCULAR DISEASES; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MALE; MEDICAL AUDIT; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; PREVENTIVE MEDICINE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; YOUNG ADULT;

EID: 64249141071     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31818dce21     Document Type: Article

References (29)

1. Sheridan S, Pignone M, Mulrow C. Framingham-based tools to calculate the global risk of coronary heart disease: a systematic review of tools for clinicians. J Gen Intern Med. 2003;18:1039-1052.
2. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143-3421.
3. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002;136:157-160.
4. Grundy SM, Cleeman JI, Mere CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
5. Pearson TA, Blair SN, Daniels SR, et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 2002;106:388-391.
6. Sheridan SL, Crespo E. Does the routine use of global coronary heart disease risk scores translate into clinical benefits or harms? A systematic review of the literature. BMC Health Serv Res. 2008;8:60.
7. van Wyk JT, van Wijk MA, Sturkenboom MC, et al. Electronic alerts versus on-demand decision support to improve dyslipidemia treatment: a cluster randomized controlled trial. Circulation. 2008;117:371-378.
8. Hall LM, Jung RT, Leese GP. Controlled trial of effect of documented cardiovascular risk scores on prescribing. BMJ. 2003;326:251-252.
9. Engberg M, Christensen B, Karlsmose B, et al. General health screenings to improve cardiovascular risk profiles: a randomized controlled trial in general practice with 5-year follow-up. J Fam Pract. 2002;51: 546-552.
10. Grover SA, Lowensteyn I, Joseph L, et al. Patient knowledge of coronary risk profile improves the effectiveness of dyslipidemia therapy: the CHECK-UP study: a randomized controlled trial. Arch Intern Med. 2007;167:2296-2303.
11. van der Weijden T, Grol R, Knottnerus J. Feasibility of a national cholesterol guideline in daily practice: a randomized controlled trial in 20 general practices. Int J Qual Health Care. 1999;11:131-137.
12. National Heart Lung and Blood Insitutue. Available at: http://hin.nhlbi. nih.gov/atpiii/calculator.asp?usertype=prof. Accessed March 20, 2008.
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
14. Persell SD, Lloyd-Jones DM, Baker DW. National Cholesterol Education Program risk assessment and potential for risk misclassification. Prev Med. 2006;43:368-371.
15. Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation. 2007;115:114-126.
16. Colwell JA. Aspirin therapy in diabetes. Diabetes Care. 2004;27(Suppl 1):S72-S73.
17. Kung HC, Hoyert DL, Xu J, et al. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56:1-120.
18. ACC/AHA Clinical Performance Measures for Primary Prevention of Cardiovascular Disease in Adults, 30-Day Public Comment Period. Available at: http://www.acc.org/qualityandscience/clinical/PPCDA.htm. Accessed February 21, 2008.
19. Van Wyk JT, Van Wijk MA. Assessment of the possibility to classify patients according to cholesterol guideline screening criteria using routinely recorded electronic patient record data. Stud Health Technol Inform. 2002;93:39-46.
20. Persell SD, Wright JM, Thompson JA, et al. Assessing the validity of national quality measures for coronary artery disease using an electronic health record. Arch Intern Med. 2006;166:2272-2277.
21. Hunt DL, Haynes RB, Hanna SE, et al. Effects of computer-based clinical decision support systems on physician performance and patient outcomes: a systematic review. JAMA. 1998;280:1339-1346.
22. Demakis JG, Beauchamp C, Cull WL, et al. Improving residents' compliance with standards of ambulatory care: results from the VA Cooperative Study on Computerized Reminders. JAMA. 2000;284:1411-1416.
23. Sequist TD, Gandhi TK, Karson AS, et al. A randomized trial of electronic clinical reminders to improve quality of care for diabetes and coronary artery disease. J Am Med Inform Assoc. 2005;12:431-437.
24. Lester WT, Grant RW, Barnett GO, et al. Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. J Gen Intern Med. 2006;21: 22-29.
25. Eccles M, McColl E, Steen N, et al. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. BMJ. 2002;325:941.
26. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for managing heart disease in primary care: a randomized, controlled trial. J Gen Intern Med. 2003;18:967-976.
27. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286:180-187.
28. Liu J, Hong Y, D'Agostino RB Sr, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291:2591-2599.
29. Marrugat J, D'Agostino R, Sullivan L, et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Community Health. 2003;57:634-638.